IA2030 Scorecard
—Global
- 1.2 Health workforce1.6 Vaccine safety2.1 Political and financial commitment2.2 Demand for immunization3.2 High & equitable coverage4.1 Life-course vaccination5.1 Outbreak detection and response6.1 Healthy global markets for vaccines6.2 Financial resources for imm. programmes6.3 Imm. expenditure from domestic resources7.1 Capacity for innovation
Type to select a Country
Impact Goal 3: Build strong immunization programmes
3.1
Deliver across the life course
Vaccination coverage across the life course—Global
First Year — DTP3
86%
2019
Baseline
83%
2020
81%
2021
84%
2022
2030 Target
90%
First Year — PCV3
51%
2019
Baseline
51%
2020
51%
2021
60%
2022
2030 Target
90%
Second Year — MCV2
71%
2019
Baseline
72%
2020
71%
2021
74%
2022
2030 Target
90%
Adolescents — HPVc
14%
2019
Baseline
12%
2020
13%
2021
15%
2022
2030 Target
90%
Summary Table
| Vaccine | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| DTP3 | 86% | 83% | 81% | 84% |
| MCV2 | 71% | 72% | 71% | 74% |
| PCV3 | 51% | 51% | 51% | 60% |
| HPVc | 14% | 12% | 13% | 15% |
Definition: Vaccination coverage across the life course (DTP3, MCV2, PCV3, HPVc)
- Numerator: Total number of target population that have received the vaccine (number of doses administered).
- Denominator: Total estimated population of the target group of children that should receive the vaccine.
Method of estimation:
Step 1) Calculate the indicator value. Calculate the coverage for each vaccine and year included in the indicator. Coverage for a certain year is defined as the proportion of the targeted population that received the relevant vaccine and dose in that year.
Note: The annually targeted population for globally recommended vaccines comprises the entire global target cohort, regardless of whether the vaccine was introduced in their country.
Data source: WHO/UNICEF Estimates of National Immunization Coverage (WUENIC), WHO/UNICEF HPV Estimates
Accessed: undefined
